ArticleAdvances in hematology2022

Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study.

Lisa M Hess et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.